Published in
Taylor and Francis Group, Expert Review of Clinical Pharmacology, 11(9), p. 1493-1503, 2016
DOI: 10.1080/17512433.2016.1221760
Links
Tools
Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 